Advertisement

Search Results

Advertisement



Your search for ,her matches 3362 pages

Showing 801 - 850


Vanderbilt University Appoints Karen Winkfield, MD, PhD, Professor of Radiation Oncology

Karen Winkfield, MD, PhD, Executive Director, Meharry-Vanderbilt Alliance, and Ingram Professor of Cancer Research, was recently promoted to Professor of Radiation Oncology at Vanderbilt University Medical Center (VUMC). “Grateful to those who paved the way,” said Dr. Winkfield on Twitter, noting...

supportive care
pain management

Early-Phase Study Rediscovers Potential Alternative to Methadone for Cancer Pain

Levorphanol was associated with improved pain and symptom control in patients with advanced cancer, according to data from an early phase I trial, reported by Akhila Reddy, MD, at the 2021 Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO)...

pancreatic cancer
immunotherapy

Tackling the Challenge of Pancreatic Cancer: New Approaches

Pancreatic cancer remains an incorrigible foe, but recent advances in genomic profiling and targeted drug development are slowly improving the outlook for patients, according to Eileen M. O’Reilly, MD, Winthrop Rockefeller Endowed Chair in Medical Oncology and Section Head,...

breast cancer
genomics/genetics

Outcomes and Behaviors Among Women Receiving or Declining Their Breast Cancer Polygenic Risk Score

A recent study examined patient-reported outcomes and risk-management behaviors of women choosing to receive or decline their breast cancer polygenic risk scores (PRS). The findings were published by Tatiane Yanes, PhD, and colleagues in Genetics in Medicine. The research aimed to look at how the...

issues in oncology

The Patient We See and the Person We May Not

A middle-aged patient was referred to our clinic with a mass in his liver. It had been detected the preceding year, and the patient underwent a battery of investigations with scans and biopsies to reach a diagnosis of metastatic lesion of the liver. After appropriate consultations with oncologists, ...

From Istanbul to Orange County, an Oncologist’s Journey to a Leadership Role in Quality Care

Pelin Cinar, MD, MS, was born and reared in Istanbul, Turkey. “My father ran a small furniture business, and my mother was a homemaker. However, I had a distant cousin who was an obstetrician-gynecologist, but he did house calls and treated any number of health issues in the community. Early on, I ...

breast cancer

HR-Positive/HER2-Positive Metastatic Breast Cancer

In this video, Drs. Sara A. Hurvitz, William J. Gradishar, and Sara M. Tolaney discuss the current treatment landscape for hormone receptor (HR)-positive, HER-positive metastatic breast cancer. Dr. Hurvitz presents the case of a 34-year-old woman with de novo metastatic estrogen...

Erica Sirrine, PhD, Named Director of Social Work at St. Jude Children’s Research Hospital

Clinical social worker, grief expert, and university dean Erica Sirrine, PhD, has been named Director of Social Work at St. Jude Children’s Research Hospital. For the past 14 years, Dr. Sirrine has worked in higher education, most recently serving as Dean of the College of Behavioral and Social...

Cleveland Clinic Cancer Center Recognizes Shilpa Gupta, MD, and Nima Sharifi, MD

Shilpa Gupta, MD, has been appointed Director of Genitourinary Medical Oncology at Taussig Cancer Institute and Co-Leader of the Genitourinary Oncology Program at Cleveland Clinic. Her research interests include novel drug development and understanding biomarkers in bladder cancer treatment. Nima ...

Sarah Tasian, MD, Appointed Chief of the Section of Hematologic Malignancies, Children’s Hospital of Philadelphia

The Division of Oncology at Children’s Hospital of Philadelphia (CHOP) has appointed Sarah Tasian, MD, as Chief of the Section of Hematologic Malignancies. Dr. Tasian succeeds Richard Aplenc, MD, PhD, MSCE, who served in this role for 13 years. Dr. Tasian will oversee a group of faculty,...

The Compelling Story of Cystic Fibrosis and the Dawn of Precision Medicine

Woe to the child who tastes salty from a kiss on the brow” was a forbidding prophecy from Medieval Europe, presaging unknown disease. Today, we know that salty skin is a telltale sign of cystic fibrosis in children, a disease that eluded medical identification until 1938, when an American...

Expert Point of View: Jaishri O. Blakeley, MD

Invited study discussant Jaishri O. Blakeley, MD, Director of the Johns Hopkins Comprehensive Neurofibromatosis Center, Baltimore, changed the title of her talk to “Finding Needles in Haystacks,” “because this is what we do with CNS [central nervous system] tumors,” she told listeners. “ALK...

Sukhmani K. Padda, MD, to Direct Thoracic Medical Oncology at Cedars-Sinai Cancer Center

Thoracic medical oncologist Sukhmani K. Padda, MD, was recently selected to direct Thoracic Medical Oncology at Cedars-Sinai Cancer Center in Los Angeles. Dr. Padda’s appointment, following a national search, reflects her breadth of experience as a clinician and researcher in the field of thoracic...

issues in oncology

Bridging the Gender Gap in Oncology

Women account for a growing proportion of the oncology workforce. Multiple studies, however, show that women oncologists are underrepresented in leadership positions, may have significantly lower salaries than men, and may be subjected to discriminatory practices stimulated by a medical culture...

breast cancer
immunotherapy

Evandro de Azambuja, MD, PhD, Discusses the Short-HER Trial

Invited discussant of the Short-HER trial, Evandro de Azambuja, MD, PhD, Head of the Medical Support Team at the Institut Jules Bordet, Brussels, acknowledged the good outcomes in low- and intermediate-risk patients treated with either a short or long duration of trastuzumab but said 1 year of the...

breast cancer
immunotherapy

Long-Term Analysis of Short-HER Trial of Adjuvant Trastuzumab

Long-term analysis of the Short-HER trial showed that 9 weeks of adjuvant trastuzumab conveyed benefits comparable to a 1-year course in patients with early HER2-positive breast cancer deemed to be at low or intermediate risk for recurrence. High-risk patients, however, derived considerably more...

ASCO Congratulates Chiquita Brooks-LaSure on Confirmation as CMS Administrator

Monica M. Bertagnolli, MD, FACS, FASCO, Board Chair of the Association for Clinical Oncology (ASCO), issued the following statement. “The Association for Clinical Oncology congratulates Chiquita Brooks-LaSure on her confirmation as Administrator of the Centers for Medicare & Medicaid Services ...

Conquer Cancer, the ASCO Foundation, Awards More Than $10 Million to Support Cancer Research

Conquer Cancer, the ASCO Foundation, is pleased to announce the recipients of its awards supporting researchers with projects spanning across many areas in cancer care, including immunotherapy, precision medicine, breast cancer, and palliative care. This year, Conquer Cancer is funding the largest...

leukemia

Being Both a Cancer Provider and a Cancer Survivor Is a Rare Privilege

Perhaps my 35-year career as a surgical oncologist and researcher specializing in soft-tissue sarcomas should have prepared me to recognize the signs of chronic lymphocytic leukemia (CLL) when they first appeared a few days before Christmas in 2016, but it did not. In fact, my symptoms were so...

The Wistar Institute Recruits Noam Auslander, PhD, as Assistant Professor

The Wistar Institute, an international biomedical research leader in cancer, immunology, and infectious diseases, recently announced the appointment of Noam Auslander, PhD, as Assistant Professor in the Molecular and Cellular Oncogenesis Program of The Wistar Institute Cancer Center. Dr....

Caryn Lerman, PhD, Elected President of the AACI

Caryn Lerman, PhD, is the new President of the Association of American Cancer Institutes (AACI). Dr. Lerman is Director of the University of Southern California (USC) Norris Comprehensive Cancer Center in Los Angeles and Associate Dean for Cancer Programs and the H. Leslie and Elaine S. Hoffman...

Study Examines Mechanisms of Resistance in Early-Stage Breast Cancer After Endocrine Plus CDK4/6 Therapy

About 80% of breast cancer cases are hormone receptor–positive, according to the American Cancer Society. Patients with estrogen receptor–positive breast cancer generally are treated using therapy that inhibits both estrogen levels and cell-cycle activity, but about 90% of patients with metastatic...

breast cancer

Improving Screening of Dense Breasts With Newer MRI Technologies

Women with dense breasts are increasingly being screened with magnetic resonance imaging (MRI), which is clearly the best way to detect small cancers in this population, according to Elizabeth Morris, MD, FACR, FSBI, FISMRM, Professor and Chair of the Department of Radiology at the University of...

supportive care

How to Talk With Teens and Young Adults About Their End-of-Life Goals

Although death rates for adolescent and young adults (AYAs) with cancer have been dropping 0.8% a year from 2009 to 2018, cancer remains a leading disease-related cause of death among this patient population. This year, the National Cancer Institute (NCI) estimates that 88,260 AYAs, defined by the...

issues in oncology
gynecologic cancers

Survey Finds Bullying, Sexual Harassment Not Uncommon for Women in Gynecologic Oncology

Female gynecologic oncologists have reported in a survey that having a department chair of the same gender is no buffer against gender harassment or discrimination in the workplace. The information comes from a survey of the “Women of Gynecologic Oncology” Facebook group and was reported in March...

NIH Names Marie A. Bernard, MD, Chief Officer for Scientific Workforce Diversity

National Institutes of Health (NIH) Director Francis S. Collins, MD, PhD, has selected Marie A. Bernard, MD, as NIH’s next Chief Officer for Scientific Workforce Diversity (COSWD). Dr. Bernard will lead NIH’s effort to promote diversity, inclusiveness, and equity throughout the biomedical research...

Expert Point of View: Kunle Odunsi, MD, PhD, and Lilian T. Gien, MD, MSc

Comments on the OUTBACK trial were provided by invited discussant Kunle Odunsi, MD, PhD, Professor of Obstetrics and Gynecology, Dean for Oncology, and Director of the University of Chicago Medicine Comprehensive Cancer Center. Lilian T. Gien, MD, MSc, Associate Professor of Oncology at the...

Gauri Varadhachary, MD, Compassionate Leader, Caring and Brilliant Physician, Dies at 52

Gauri Varadhachary, MD, Clinical Professor in Gastrointestinal (GI) Medical Oncology at The University of Texas MD Anderson Cancer Center, died on June 5, 2021. She was 52. A member of the MD Anderson community for nearly 20 years, Dr. Varadhachary was remembered for her dedication to her patients, ...

breast cancer

Breast Cancer Has Taught Me Many Life Lessons

In 2016, 2 years before I was diagnosed with stage III estrogen and progesterone receptor–positive, HER2-negative, invasive ductal carcinoma in situ in my left breast, I had felt a mass in my right breast that turned out to be a benign fibroid. When I felt a mass in my left breast one morning while ...

issues in oncology
survivorship

Addressing Sexuality Challenges Throughout the Cancer Care Continuum

Multiple studies have shown that sexuality and intimacy problems are common among patients with cancer, often beginning at the time of diagnosis and persisting through the continuum of care into the survivorship setting. Although these problems have been well documented, many patients and survivors ...

John D. Carpten, PhD, FAACR, to Join the AACR Board of Directors

The American Association for Cancer Research (AACR) recently announced that John D. Carpten, PhD, FAACR, has been elected by the association to serve on its Board of Directors. Dr. Carpten has accepted the position previously held by Karen E. Knudsen, MBA, PhD, who is stepping down to fulfill her...

Inaugural Vice Chair for Diversity & Health Equity Appointed by NYU Langone/NYU Grossman School of Medicine

New York University (NYU) Langone/NYU Grossman School of Medicine recently announced that Kathie-Ann Joseph, MD, MPH, has been promoted to the rank of Professor in Surgery. Dr. Joseph has also assumed the rank of Professor in Population Health. In addition, Dr. Joseph has been named the inaugural...

Innovator in Treatment of Infectious Diseases, Francisco Marty, MD, Dies at 53

The Brigham and Women’s hospital community mourns the loss of Francisco Marty, MD, of the Division of Infectious Diseases, who died April 8, 2021, after a tragic accident while hiking in the Dominican Republic. He was 53. A member of the Brigham community for more than 20 years, Dr. Marty is...

geriatric oncology

Do Community Oncologists Have Access to Geriatric Specialty Care for Older Patients?

As our population rapidly ages, the burden of cancer incidence increases accordingly, creating an urgent need for greater and more incisive research on the diagnosis, treatment, and survivorship issues for older adults with cancer. Given the numerous challenges faced by today’s busy oncologists, a...

Expert Point of View: Rana R. McKay, MD

Invited discussant of the KEYNOTE-564 trial, Rana R. McKay, MD, Associate Professor of Medicine and Urology at the University of California San Diego, offered these comments about these trial results. “This is a positive study, showing a 32% reduction in the risk of recurrence or death with...

global cancer care

Cancer in Morocco: Access to Innovative Treatments and Research Status

Morocco is an Arab country in North Africa. It covers 716,550 square kilometers and has a population of nearly 36 million. The median age is 29.3 years. Morocco’s estimated gross domestic product (GDP) in 2019 was $122 million. As of 2019, Morocco’s health budget was equivalent to 4.5% of the total ...

Whispers Over My Shoulder

When I interviewed for my current post as a first-time consultant in medical oncology in the United Kingdom, I was asked about my 5-year career plan. I remember some detail of my reply, but I don’t think it even remotely encompassed the depth of insight I would gain from the patients I’ve treated...

Young Urologist of the Year Award Winners

Established by Michael C. Ost, MD, MBA, the 2012–2013 American Urological Association Young Urologists Committee Chair, the Young Urologist of the Year Award is presented annually to select early-career association members in recognition of their efforts and commitment to advancing the development...

AACR CEO Margaret Foti, PhD, MD (hc), to Receive Gallery of Success Award From Temple University

Margaret Foti, PhD, MD (hc), Chief Executive Officer (CEO) of the American Association for Cancer Research (AACR), has been selected as a Temple University Gallery of Success honoree for 2021. Each year, Temple University showcases exceptional alumni from its 17 schools and colleges in its Gallery...

Cynthia M. Yoshida, MD, Honored Nationally for Increasing Colorectal Cancer Screening Rates

Cynthia M. Yoshida, MD, is one of six winners of a national award recognizing health-care providers and institutions for their work to increase colorectal cancer screening rates. Dr. Yoshida, a gastroenterologist and medical leader of the University of Virginia (UVA) Cancer Center’s Colorectal...

Chanita Hughes-Halbert, PhD, to Advance Cancer Equity at USC Norris Comprehensive Cancer Center

Chanita Hughes-Halbert, PhD, will join the University of Southern California (USC) Norris Comprehensive Cancer Center as Associate Director for Cancer Equity, a newly created position, and the Keck School of Medicine of USC as Professor and Vice Chair of Research in the Department of Preventive...

Mary Daly, MD, PhD, FACP, Receives NCCN’s 2021 Rodger Winn Award

The National Comprehensive Cancer Network (NCCN) recently presented Mary B. Daly, MD, PhD, FACP, Professor in the Department of Clinical Genetics and Director of the Risk Assessment Program at Fox Chase Cancer Center, with the Rodger Winn Award. The Rodger Winn Award is given annually to one NCCN...

issues in oncology
lymphoma
leukemia
kidney cancer
cns cancers

Study Explores Incidence Rates for Various Pediatric Cancers Across Age and Racial Groups

New research has uncovered substantial differences in the rates of childhood cancers when considering a single year of age rather than grouping several years together. The study, published by Marcotte et al in the journal Cancer, also found that minority children seem to have different risks than...

breast cancer
symptom management

Survivors of Early-Stage Breast Cancer Face Broad Range of Symptoms and Concerns

Patients with early-stage breast cancer may be at low risk of dying of their disease, but they experience a high burden of physical and psychological symptoms long after their treatment has ended, according to data presented during the 2021 American Society of Breast Surgeons Annual Meeting.1...

Carol L. Prives, PhD, FAACR, Receives 2021 AACR–G.H.A. Clowes Award for Outstanding Basic Cancer Research

The American Association for Cancer Research (AACR) presented Carol L. Prives, PhD, FAACR, with the 2021 AACR–G.H.A. Clowes Award for Outstanding Basic Cancer Research during the virtual AACR Annual Meeting 2021. Dr. Prives, the Da Costa Professor of Biology in the Department of Biological Sciences ...

Pershing Square Sohn Cancer Research Alliance Awards $3.6 Million to Six Emerging Pioneers in Cancer Research

The Pershing Square Sohn Cancer Research Alliance has announced the winners of the 2021 Pershing Square Sohn Prize for Young Investigators in Cancer Research, awarded annually to cancer research scientists and physician-scientists based in the greater New York City area. The prize, totaling $3.6...

colorectal cancer

Data Analysis on Early-Onset Colorectal Cancer Sheds Light on the Rising Rates in Young Adults

In May 2021, the U.S. Preventive Services Task Force (USPSTF) announced that it was updating its recommendation for when individuals at average risk of colorectal cancer should begin screening. Echoing the recommendation from the American Cancer Society in 2018, the USPSTF now recommends that those ...

issues in oncology

First Lady Dr. Jill Biden Assures the NCI of the Administration’s Commitment to Advancing Cancer Research

In a virtual visit to the National Cancer Institute (NCI) on February 3, 2021, just 2 weeks after her husband, Joe Biden, was sworn in as the 46th President of the United States, First Lady Jill Biden, EdD, recounted that, in her many years of travel across the United States, she learned that...

palliative care

The Daughter of a Fighter Pilot Becomes a Leader in Compassionate Cancer Care

Jamie H. Von Roenn, MD, FASCO, grew up in the suburbs of Chicago as the middle child of three girls. She was, by her own account, extremely shy by nature. Her mother was a graduate of the University of Chicago, but her father’s college education was preempted by his service as a fighter pilot in...

Working on the Night Shift, a Connection to a Patient With Cancer Inspires a Career

Jaap Verweij, MD, PhD, FASCO, was born in 1953 in Velsen, a municipality situated on both sides of the massive North Sea Canal in the Netherlands. His father was a sea captain, and other close family members also plied the oceans for a living in the fishing or transport industries. Dr. Verweij...

Advertisement

Advertisement




Advertisement